These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 10448545

  • 1. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group.
    Diener HC.
    Cephalalgia; 1999 Jul; 19(6):581-8; discussion 542. PubMed ID: 10448545
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms.
    Diener HC, Eikermann A, Gessner U, Göbel H, Haag G, Lange R, May A, Müller-Schwefe G, Voelker M.
    Eur Neurol; 2004 Jul; 52(1):50-6. PubMed ID: 15240983
    [Abstract] [Full Text] [Related]

  • 3. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan.
    Silberstein S, Winner PK, McAllister PJ, Tepper SJ, Halker R, Mahmoud RA, Siffert J.
    Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
    [Abstract] [Full Text] [Related]

  • 4. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [Abstract] [Full Text] [Related]

  • 5. Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: a multicentre double-blind placebo-controlled study.
    Chabriat H, Joire JE, Danchot J, Grippon P, Bousser MG.
    Cephalalgia; 1994 Aug; 14(4):297-300. PubMed ID: 7954760
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study.
    Landy S, Munjal S, Brand-Schieber E, Rapoport AM.
    J Headache Pain; 2018 Aug 15; 19(1):69. PubMed ID: 30112726
    [Abstract] [Full Text] [Related]

  • 7. Oral sumatriptan for migraine in children and adolescents: a randomized, multicenter, placebo-controlled, parallel group study.
    Fujita M, Sato K, Nishioka H, Sakai F.
    Cephalalgia; 2014 Apr 15; 34(5):365-75. PubMed ID: 24163282
    [Abstract] [Full Text] [Related]

  • 8. Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine.
    Diamond S, Elkind A, Jackson RT, Ryan R, DeBussey S, Asgharnejad M.
    Arch Fam Med; 1998 Apr 15; 7(3):234-40. PubMed ID: 9596457
    [Abstract] [Full Text] [Related]

  • 9. Comparison of intravenous valproate with intravenous lysine-acetylsalicylic acid in acute migraine attacks.
    Leniger T, Pageler L, Stude P, Diener HC, Limmroth V.
    Headache; 2005 Jan 15; 45(1):42-6. PubMed ID: 15663612
    [Abstract] [Full Text] [Related]

  • 10. Comparison of subcutaneous sumatriptan with usual acute treatments for migraine. French Sumatriptan Study Group.
    Boureau F, Chazot G, Emile J, Bertin L, d'Allens H.
    Eur Neurol; 1995 Jan 15; 35(5):264-9. PubMed ID: 8542914
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: an 8-week open-label extension study.
    Landy S, Munjal S, Brand-Schieber E, Rapoport AM.
    J Headache Pain; 2018 Aug 15; 19(1):70. PubMed ID: 30112725
    [Abstract] [Full Text] [Related]

  • 12. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J, Cady R, Singer R, Peters K, Webster C, Kori S, Byrd S.
    Clin Ther; 2006 Apr 15; 28(4):517-26. PubMed ID: 16750463
    [Abstract] [Full Text] [Related]

  • 13. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
    Lipton RB, Munjal S, Brand-Schieber E, Rapoport AM.
    Headache; 2018 May 15; 58(5):676-687. PubMed ID: 29878341
    [Abstract] [Full Text] [Related]

  • 14. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F, Sheftell F, Silberstein S, Cady R, Ruoff G, Krishen A, Peykamian M.
    Headache; 2012 Apr 15; 52(4):530-43. PubMed ID: 22103635
    [Abstract] [Full Text] [Related]

  • 15. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group.
    Eur Neurol; 1991 Apr 15; 31(5):323-31. PubMed ID: 1653140
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M.
    Clin Ther; 2007 Jan 15; 29(1):99-109. PubMed ID: 17379050
    [Abstract] [Full Text] [Related]

  • 17. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks.
    Diener HC, Bussone G, de Liano H, Eikermann A, Englert R, Floeter T, Gallai V, Göbel H, Hartung E, Jimenez MD, Lange R, Manzoni GC, Mueller-Schwefe G, Nappi G, Pinessi L, Prat J, Puca FM, Titus F, Voelker M, EMSASI Study Group.
    Cephalalgia; 2004 Nov 15; 24(11):947-54. PubMed ID: 15482357
    [Abstract] [Full Text] [Related]

  • 18. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial.
    Brandes JL, Kudrow D, Stark SR, O'Carroll CP, Adelman JU, O'Donnell FJ, Alexander WJ, Spruill SE, Barrett PS, Lener SE.
    JAMA; 2007 Apr 04; 297(13):1443-54. PubMed ID: 17405970
    [Abstract] [Full Text] [Related]

  • 19. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.
    Savani N, Brautaset NJ, Reunanen M, Szirmai I, Ashford EA, Hassani H, Saiers J.
    Int J Clin Pract Suppl; 1999 Aug 04; 105():7-15. PubMed ID: 10692717
    [Abstract] [Full Text] [Related]

  • 20. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine.
    Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G.
    Lancet; 1995 Oct 07; 346(8980):923-6. PubMed ID: 7564725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.